In part 2 of this slideshow series, take a look back at the novel drugs and therapeutics approved by the FDA in 2023,1 including treatments for amyotrophic lateral sclerosis (ALS), vasomotor symptoms of menopause, and migraine.References1. Novel drug approvals for 2023. FDA. Reviewed November 28, 2023. Accessed November 28, 2023. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-20232. Pfizer’s Zavzpret (zavegepant) migraine […]
